Premium
PPARγ agonists in type 2 diabetes: how far have we come in ‘preventing the inevitable’? A review of the metabolic effects of rosiglitazone
Author(s) -
Zinman Bernard
Publication year - 2001
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1046/j.1463-1326.2001.00033.x
Subject(s) - citation , rosiglitazone , type 2 diabetes , medicine , library science , diabetes mellitus , endocrinology , computer science